Заболевания нервной системы, коморбидные псориазу

Литература:
1. Белялов Ф.И. Двенадцать тезисов коморбидности. Клиническая медицина 2009; 12: 69-71
2. Вёрткин А.Л., Зайратьянц О. В., Вовк Е.И. Окончательный диагноз. М.: ГЭОТАР, 2008; 576 с.
3. Fortin М, et al. Multimorbidity and quality of life in primary care: a systematic review. Health Qual Life Outcomes 2004; 20 (2): 51
4. Бакулев А.Л., Штода Ю.М., Утц С.Р. К вопросу о коморбидности при псориазе. Саратовский научно-медицинский журнал 2014; 10 (3): 537-539
5. Schwandt A, et al. Psoriasis and Diabetes: A Multicenter Study in 222078 Type 2 Diabetes Patients Reveals High Levels of Depression. Journal of Diabetes Research Volume 2015; Article ID 792968, 10 pages
6. Phan C, et al. Metabolic comorbidities and hypertension in psoriasis patients in France. Comparisons with French national databases. Ann Dermatol Venereol 2016; 143 (4): 264-274
7. Кунгуров H.B., Филимонкова H.H., Топычканова Е.П., Киселева Н.В., Кохан М.М. Коморбидная сердечно-сосудистая патология у больных вульгарным псориазом. Лечащий врач 2014; (9)
8. Жук A.H., Mopрисон А. В., Еремина М.Г. Псориаз и кардиоваскулярный синдром: общие причины (клиническое наблюдение). http://medconfer.com/node/6898)
9. Griffiths СЕМ, Barker JNWN. Pathogenesis and clinical features of psoriasis. Lancet 2007; 370: 263-371
10. Rapp SR, Feldman SR, Exum ML, et al. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 1999; 41: 401-407
11. Ruth AM, Nadia R, Jeffrey C, et al. A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis. Multiple Sclerosis Journal 2015; 21 (3): 282-293
12. FellnerA, DanoM, Regev K, MosekA, Kami A. Multiple sclerosis is associated with psoriasis: A case-control study. J Neurol Sci 2014; 338 (1 -2): 226-8. doi: 10.1016/j.jns.2014.01.003
13. Kolb-Maurer A, Goebeler M, Maurer M. Cutaneous Adverse Events Associated with lnterferon-p Treatment of Multiple Sclerosis. Int J Mol Sci 2015; 16 (7): 14951-60. doi: 10.3390/ijms160714951
14. Marco G, Marina Ti, Alessandro DS, et al. Linear psoriasis following the typical distribution of the sciatic nerve. J Dermatol Case 2015; 9 (1): 6-11
15. Chroni E, MonastirliA, Georgiou S, etal. Sensorimotor polyneuropathy after a 1 -month treatment with oral acitretin. Clin Neuropharmacol 2014; 37 (5): 151-153
16. FoulkesAC, Wheeler L, Gosal D, etal. Development of chronic inflammatory demyelinating polyneuropathy in a patient receiving infliximab for psoriasis. Br J Dermatol 2014; 170 (1): 206-209
17. Nozaki K, Silver RM, Stickler DE, et al. Neurological deficits during treatment with tumor necrosis factor-alpha antagonists. Am J Med Sci 2011; 342 (5); 352-355
18. Marcela C, Miguel G, Sergio J. Successful rechallenge with anti-tumor necrosis factor for psoriatic arthritis after development of demyelinating nervous system disease during initial treatment: comment on the article by Mohan et al. Arthritis & Rheumatism 2002; 46 (11): 3102-3114
19. Chroni E, Georgiou S, Polychronopoulos P, et al. Peripheral large nerve fibre function in patients with chronic plaque psoriasis. Eur J Neurol 2007; 14 (1): 18-20
20. Stern RS, Nijsten T, Feldman SR, et al. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc 2004; 9: 136-139
21. Gupta MA, Gupta AK. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol 1998; 139: 846-850
22. Sampogna F, Tabolli S, Mastroeni S, et al. Quality of life impairment and psychological distress in elderly patients with psoriasis. Dermatology 2007; 215: 341-347
23. Кикта С.В., Дробижев М.Ю., Белоусова Т.А. Депрессии у больных псориазом. Фарматека 2010; 11
24. Langan SM, Seminara NM, Shin DB, et al. Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom. J Invest Dermatol 2012; 132: 556-562
25. Armstrong AW, Schupp C, Bebo B. Psoriasis comorbidities: results from the National Psoriasis Foundation surveys 2003 to 2011. Dermatology 2012; 225: 121-126
26. Российское общество дерматовенерологов и косметологов. Федеральные клинические рекомендации по ведению больных псориазом. М., 2015. http://www.cnikvi.ru/docs/clinic_recs/ bolezni-kozhi-i-pridatkov -kozhi/
27. Dougados М, Linden S van der, Juhlin R, et al. The European Spondyloarthropathy Study Group preliminary criteria for the classification of spondyloarthropathy. Arthritis Rheum.1991;34(10): 1218-27
28. Избранные лекции по клинической ревматологии. Под ред. В. А. Насоновой, Н.В. Бунчука. М.: Медицина, 2001
29. Manger В. Checkliste XX 3. — 15. Auflage — Stuttgart — New York: Georg Thieme Verlag. L Rheumatologie, 2005; 586 p.